Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chirag Amin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Handbook of Clinical Neurology|December 25, 2013
Bleeding diathesis and hemophiliasChirag Amin, Anjali Sharathkumar, Anne Griest
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Microparticles and cancerChirag Amin, Nigel Mackman, Nigel S Key
Thrombosis Research|May 25, 2010
African-Americans have a higher rate of proximal deep vein thrombosis at presentationTyler W Buckner, Chirag Amin, Denise A Esserman, et al.
Leukemia Research|December 16, 2014
Pilot study of erlotinib in patients with acute myeloid leukemiaHamid Sayar, Magdalena Czader, Chirag Amin, et al.
Urology|August 8, 2008
Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomyChirag Amin, Eric Wallen, Raj S Pruthi, et al.
Clinical Nephrology|November 6, 2014
Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myelomaSandra M S Herrmann, Mahendra V Govani, Mary E Fidler, et al.
Surgical Neurology International|May 5, 2022
Gorham-Stout disease: A multirod lumbar reconstruction with off-label suppression-remission therapyAjay Krishnan, Aditya Raj, Devanand Degulmadi, et al.
Leukemia & Lymphoma|December 14, 2011
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemiaMatthew C Foster, Chirag Amin, Peter M Voorhees, et al.
British Journal of Haematology|October 30, 2015
Coagulation activation in sickle cell trait: an exploratory studyChirag Amin, Soheir Adam, Micah J Mooberry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinomaC Lance Cowey, Chirag Amin, Raj S Pruthi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Handbook of Clinical Neurology|December 25, 2013
Bleeding diathesis and hemophiliasChirag Amin, Anjali Sharathkumar, Anne Griest
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Microparticles and cancerChirag Amin, Nigel Mackman, Nigel S Key
Thrombosis Research|May 25, 2010
African-Americans have a higher rate of proximal deep vein thrombosis at presentationTyler W Buckner, Chirag Amin, Denise A Esserman, et al.
Leukemia Research|December 16, 2014
Pilot study of erlotinib in patients with acute myeloid leukemiaHamid Sayar, Magdalena Czader, Chirag Amin, et al.
Urology|August 8, 2008
Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomyChirag Amin, Eric Wallen, Raj S Pruthi, et al.
Clinical Nephrology|November 6, 2014
Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myelomaSandra M S Herrmann, Mahendra V Govani, Mary E Fidler, et al.
Surgical Neurology International|May 5, 2022
Gorham-Stout disease: A multirod lumbar reconstruction with off-label suppression-remission therapyAjay Krishnan, Aditya Raj, Devanand Degulmadi, et al.
Leukemia & Lymphoma|December 14, 2011
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemiaMatthew C Foster, Chirag Amin, Peter M Voorhees, et al.
British Journal of Haematology|October 30, 2015
Coagulation activation in sickle cell trait: an exploratory studyChirag Amin, Soheir Adam, Micah J Mooberry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinomaC Lance Cowey, Chirag Amin, Raj S Pruthi, et al.
Pageof 1